ACADIAN ASSET MANAGEMENT LLC - CHINA SXT PHARMACEUTICALS IN ownership

CHINA SXT PHARMACEUTICALS IN's ticker is SXTC and the CUSIP is G2161P108. A total of 7 filers reported holding CHINA SXT PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
ACADIAN ASSET MANAGEMENT LLC ownership history of CHINA SXT PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$14,000
-97.4%
56,253
-94.4%
0.00%
-100.0%
Q2 2020$531,000
+5210.0%
1,007,546
+5701.5%
0.00%
Q1 2020$10,00017,3670.00%
Other shareholders
CHINA SXT PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
Hudock, Inc. 7,500$2,0000.00%
UBS Group AG 55,184$18,0000.00%
FIFTH THIRD BANCORP 1,000$00.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
GEODE CAPITAL MANAGEMENT, LLC 106,568$35,0000.00%
SUSQUEHANNA INTERNATIONAL GROUP, LLP 36,886$12,0000.00%
Renaissance Technologies 664,647$218,0000.00%
View complete list of CHINA SXT PHARMACEUTICALS IN shareholders